TipRanks
Advertisement
Advertisement
Hold Rating Reiterated on Alector as Early-Stage Alzheimer’s Pipeline Keeps Risk–Reward Balanced
PremiumRatingsHold Rating Reiterated on Alector as Early-Stage Alzheimer’s Pipeline Keeps Risk–Reward Balanced
2M ago
Alector reports Q2 EPS (21c), consensus (23c)
Premium
The Fly
Alector reports Q2 EPS (21c), consensus (23c)
2M ago
Alector Ends GSK Collaboration, Retires Hercules Capital Debt
Premium
Company Announcements
Alector Ends GSK Collaboration, Retires Hercules Capital Debt
3M ago
Buy Rating on Alector: Strategic Pivot to Blood–Brain-Barrier Platform and Emerging Alzheimer’s Assets AL137 and AL064 Underpins Attractive Risk–Reward
PremiumRatingsBuy Rating on Alector: Strategic Pivot to Blood–Brain-Barrier Platform and Emerging Alzheimer’s Assets AL137 and AL064 Underpins Attractive Risk–Reward
8M ago
Alector: Holding Amid Pipeline Setback as ABC Brain Delivery Platform Awaits Clinical Validation
Premium
Ratings
Alector: Holding Amid Pipeline Setback as ABC Brain Delivery Platform Awaits Clinical Validation
8M ago
Alector reports Q4 EPS (34c), consensus (36c)
Premium
The Fly
Alector reports Q4 EPS (34c), consensus (36c)
8M ago

Trending

Name
Price
Price Change
S&P 500
―
Dow Jones
―
Nasdaq 100
―